Instant digital pathology market seen reaching $2.85 billion by 2030

The instant digital pathology market is projected to grow from $1.22 billion in 2025 to $2.85 billion by 2030, driven by demand for faster cancer diagnosis, remote review and AI-enabled workflows. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Instant digital pathology is becoming a faster route to biopsy review and cancer diagnosis. - The market’s projected growth signals broader adoption of digital workflows across clinical labs and hospitals. - Remote review and AI support could help shorten turnaround times for pathology decisions.

What happened: - The Business Research Company released its Instant Digital Pathology Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report puts the instant digital pathology market at $1.22 billion in 2025. - The market is projected to rise to $1.44 billion in 2026. - The report forecasts the market will reach $2.85 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report is available as a free sample and as the full market report.

The details: - Instant digital pathology uses high-speed slide scanning and digital microscopy to turn tissue samples into virtual slides for on-screen review. - Cloud connectivity and artificial intelligence allow pathologists to analyze biopsies without waiting for physical slide transport. - The report says the market’s historical growth has been driven by demand for quicker cancer diagnosis, digital healthcare adoption, workflow streamlining, rising chronic and oncological disease rates, and remote diagnostic services. - The forecast period is driven by precision medicine adoption, decentralized pathology services, demand for better diagnostic accuracy, investment in laboratory technology, and broader use of virtual pathology consultations. - Anticipated trends include ultra-fast whole slide imaging, stronger remote pathology platforms, automated tissue analysis workflows, high-resolution digital microscopes and tighter integration with laboratory information systems. - The report says digital pathology converts glass slides into high-resolution digital images with whole-slide scanners. - A January 2025 Labcorp figure showed about one-third, or 33%, of clinical labs had adopted whole-slide imaging technology.

Between the lines: - The market outlook suggests pathology is shifting from a lab-bound process to a more distributed, software-enabled workflow. - The combination of faster imaging, remote access and AI points to pressure on labs to improve speed without sacrificing diagnostic quality. - The Labcorp adoption figure suggests uptake is already underway, even with cost concerns still present.

What's next: - The report expects wider use of ultra-fast whole slide imaging for real-time assessments. - More pathology platforms are likely to add remote consultation features and automation tools. - Compatibility with laboratory information systems should become a more important buying criterion as digital pathology deployments expand. - Asia-Pacific’s growth trajectory will be a key area to watch as the market scales.